Marie-Lyn Horlacher-Hecht is a partner at Oliver Wyman in Zurich. She leads the Healthcare and Life Sciences Practice in Switzerland and specializes in innovation and growth strategies.
The Swiss national works with the leading biopharma companies and the biotech and MedTech industry. Marie-Lyn Horlacher-Hecht collaborates with clients and teams worldwide, emphasizing an inclusive work environment. Her experience shows that inclusive workgroups achieve the best results.
My passion is improving patients' quality of life through innovative therapies. New drug development approaches and ongoing business investments are required to achieve this advancement
Marie-Lyn Horlacher-Hecht has more than 15 years of experience in the biomedical industry. Many years as a strategy consultant have made her an expert in the local and international pharmaceutical and healthcare markets. She has published numerous white papers on current topics, including internal versus external innovation strategies. The Lucerne native is multilingual and internationally active. Her earlier posts were in Boston, Munich, and Berlin.
Marie-Lyn earned her PhD in biochemistry at ETH Zurich, researching new therapies at the Max Planck Institute and Harvard Medical School before her consulting work.
The life sciences industry has seen a surge in innovation in recent years due to new technologies and digital advances. Now the challenge is to help companies realize forward-looking business models in this changing market environment